Business
Dose escalates In Phase I Clinical Trial of New Oncolytic Vi
Dose escalates In Phase I Clinical Trial of New Oncolytic Vi
About this update from Imugene Ltd
[{"type":"text","content":"Imugene Ltd has released a press release. View Attachment","length":219,"tagName":"div"}]